COLFAX REPORTS SECOND QUARTER 2016 RESULTS Annapolis

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
COLFAX REPORTS SECOND QUARTER 2016 RESULTS

Annapolis Junction, MD, July 28, 2016 (GLOBE NEWSWIRE) --

  • Second quarter net income per dilutive share of $0.32, adjusted net income per share of $0.41.
  • Tightening EPS guidance range by raising bottom of range five cents.
  • Additional cost reductions actions in response to continuing end market weakness.

ANNAPOLIS JUNCTION, MD - July 28, 2016 - Colfax Corporation (NYSE: CFX), a leading global manufacturer of gas- and fluid-handling and fabrication technology products and services, today announced its financial results for the second quarter ended July 1, 2016.

For the second quarter of 2016, net income was $39.8 million, or $0.32 per dilutive share, compared to $53.1 million, or $0.42 per share, for the second quarter of 2015. Adjusted net income (as defined below) was $50.3 million, or $0.41 per share, compared to $63.0 million for the second quarter of 2015, or $0.50 per share.

Net sales were $957.2 million in the second quarter, a decrease of 6.7% from the prior year. Net sales decreased 5.6% organically compared to the second quarter of 2015. Second quarter operating income was $73.1 million, with adjusted operating income (as defined below) of $87.6 million. Operating income margin for the second quarter was 7.6% and adjusted operating income margin (as defined below) was 9.1% in the second quarter.

Second quarter gas- and fluid-handling orders decreased by 11.3% to $445.7 million compared to orders of $502.3 million for the second quarter of 2015, an organic order decline of 15.5%. Gas- and fluid-handling finished the period with backlog of $1,068.9 million.

For the six months ended July 1, 2016 net income was $62.4 million, or $0.51 per dilutive share. Adjusted net income (as defined below) was $87.2 million, or $0.71 per share. Net sales for the six months ended July 1, 2016 were $1.8 billion, a decrease of 5.3% compared to net sales for the six months ended June 26, 2015. Operating income for the six months ended July 1, 2016 was $121.5 million, with adjusted operating income (as defined below) of $153.7 million. Operating income margin for the six months ended July 1, 2016 was 6.6% and adjusted operating income margin (as defined below) for the six months ended July 1, 2016 was 8.4%.

Adjusted net income, adjusted net income per share, adjusted operating income, adjusted operating income margin, organic sales decrease and organic order decrease are not financial measures calculated in accordance with generally accepted accounting principles in the U.S. (“GAAP”). See below for a description of the measures’ usefulness and a reconciliation of these measures to their most directly comparable GAAP financial measures.

Matthew Trerotola, President and Chief Executive Officer, stated, “We delivered another solid performance in the second quarter despite ongoing market headwinds. We have several bright spots gaining momentum in the business, especially in our Fabrication Technology segment where our cost and productivity efforts are improving financial performance. However, we continue to see oil and gas project delays and weakness in our Gas and Fluid Handling markets. In response, we have initiated additional, structural cost reduction actions to improve profitability even if the market does not return to growth in near term.”

Non-GAAP Financial Measures and Other Adjustments

Colfax has provided in this press release financial information that has not been prepared in accordance with GAAP. These non-GAAP financial measures are adjusted net income, adjusted net income per share, adjusted operating income, adjusted operating income margin, organic sales decrease and organic order decrease. Adjusted net income, adjusted net income per share, adjusted operating income and adjusted operating income margin exclude Restructuring and other related charges. Adjusted net income and adjusted net income per share for the three and six months ended June 26, 2015 exclude the write-off of certain deferred financing fees and original issue discount associated with the refinancing of Colfax’s credit agreement. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 30.9% and 30.1% for the three and six months ended July 1, 2016, respectively. The effective tax rates used to calculate adjusted net income and adjusted net income per share are 28.3% and 28.8% for the three and six months ended June 26, 2015, respectively. Organic sales decrease and organic order decrease exclude the impact of acquisitions and foreign exchange rate fluctuations. These non-GAAP financial measures assist Colfax in comparing its operating performance on a consistent basis because, among other things, they remove the impact of restructuring and other related charges and write-off of certain deferred financing fees and original issue discount.

Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.

Conference Call and Webcast

Colfax will host a conference call to provide details about its results on Thursday, July 28, 2016 at 8:00 a.m. EDT. The call will be open to the public through 877-303-7908 (U.S. callers) or 678-373-0875 (international callers) and referencing the conference ID number 51227291, or through webcast via Colfax’s website at www.colfaxcorp.com under the “Investors” section. Access to a supplemental slide presentation can also be found at the Colfax website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.

About Colfax Corporation

Colfax Corporation is a diversified global manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under the Howden, Colfax Fluid Handling and ESAB brands. Colfax believes that its brands are among the most highly recognized in each of the markets that it serves. Colfax is traded on the NYSE under the ticker “CFX.” Additional information about Colfax is available at www.colfaxcorp.com.

CAUTIONARY NOTE CONCERNING FORWARD LOOKING STATEMENTS:

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning Colfax’s plans, objectives, expectations and intentions and other statements that are not historical or current fact. Forward-looking statements are based on Colfax’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause Colfax’s results to differ materially from current expectations include, but are not limited to factors detailed in Colfax’s reports filed with the U.S. Securities and Exchange Commission including its 2015 Annual Report on Form 10-K under the caption “Risk Factors.” In addition, these statements are based on a number of assumptions that are subject to change. This press release speaks only as of the date hereof. Colfax disclaims any duty to update the information herein.

The term “Colfax” in reference to the activities described in this press release may mean one or more of Colfax’s global operating subsidiaries and/or their internal business divisions and does not necessarily indicate activities engaged in by Colfax Corporation.

Colfax Corporation Condensed Consolidated Statements of Income Dollars in thousands, except per share data (Unaudited)

 Three Months Ended Six Months Ended
 July 1, 2016 June 26, 2015 July 1, 2016 June 26, 2015
        
Net sales$957,249  $1,025,375  $1,834,092  $1,936,445 
Cost of sales656,144  697,338  1,252,466  1,313,970 
Gross profit301,105  328,037  581,626  622,475 
Selling, general and administrative expense213,553  222,629  427,940  435,861 
Restructuring and other related charges14,490  8,834  32,158  12,587 
Operating income73,062  96,574  121,528  174,027 
Interest expense8,711  14,249  17,831  26,293 
Income before income taxes64,351  82,325  103,697  147,734 
Provision for income taxes20,388  23,496  33,524  32,630 
Net income43,963  58,829  70,173  115,104 
Less: income attributable to noncontrolling interest, net of taxes4,209  5,702  7,804  9,921 
Net income attributable to Colfax Corporation$39,754  $53,127  $62,369  $105,183 
Net income per share - basic$0.32  $0.43  $0.51  $0.85 
Net income per share - diluted$0.32  $0.42  $0.51  $0.84 

Colfax Corporation Reconciliation of GAAP to Non-GAAP Financial Measures Dollars in thousands, except per share data (Unaudited)

 Three Months Ended Six Months Ended
 July 1, 2016 June 26, 2015 July 1, 2016 June 26, 2015
Adjusted Operating Income       
Operating income$73,062  $96,574  $121,528  $174,027 
Operating income margin7.6% 9.4% 6.6% 9.0%
Restructuring and other related charges14,490  8,834  32,158  12,587 
Adjusted operating income$87,552  $105,408  $153,686  $186,614 
Adjusted operating income margin9.1% 10.3% 8.4% 9.6%
 Three Months Ended Six Months Ended
 July 1, 2016 June 26, 2015 July 1, 2016 June 26, 2015
Adjusted Net Income and Adjusted Net Income Per Share       
Net income attributable to Colfax Corporation$39,754  $53,127  $62,369  $105,183 
Restructuring and other related charges14,490  8,834  32,158  12,587 
Debt extinguishment charges- Refinancing of credit agreement—  4,731  —  4,731 
Tax adjustment(1)(3,970) (3,643) (7,368) (14,905)
Adjusted net income$50,274  $63,049  $87,159  $107,596 
Adjusted net income margin5.3% 6.1% 4.8% 5.6%
Weighted-average shares outstanding - diluted123,036,457  125,261,738  123,143,437  125,181,467 
Adjusted net income per share$0.41  $0.50  $0.71  $0.86 
        
Net income per share— diluted (in accordance with GAAP)$0.32  $0.42  $0.51  $0.84 

__________ (1) The effective tax rates used to calculate adjusted net income and adjusted net income per share are 30.9% and 30.1% for the three and six months ended July 1, 2016, respectively, and 28.3% and 28.8% for the three and six months ended June 26, 2015.

Colfax Corporation Change in Sales, Orders and Backlog Dollars in millions (Unaudited)

 Net Sales Orders  
 $ % $ %    
            
For the three months ended June 26, 2015$1,025.4    $502.3       
Components of Change:           
Existing Businesses(57.2) (5.6)% (78.0) (15.5)%    
Acquisitions(1)28.1  2.7% 38.4  7.6%    
Foreign Currency Translation(39.1) (3.8)% (17.0) (3.4)%    
Total(68.2) (6.7)% (56.6) (11.3)%    
For the three months ended July 1, 2016$957.2    $445.7       
            
 Net Sales Orders Backlog at Period End
 $ % $ % $ %
            
As of and for the six months ended June 26, 2015$1,936.4    $949.3    $1,364.4   
Components of Change:           
Existing Businesses(59.7) (3.1)% (119.5) (12.6)% (230.7) (16.9)%
Acquisitions(1)50.3  2.6% 61.8  6.5% 54.4  4.0%
Foreign Currency Translation(92.9) (4.8)% (38.3) (4.0)% (119.2) (8.8)%
Total(102.3) (5.3)% (96.0) (10.1)% (295.5) (21.7)%
As of and for the six months ended July 1, 2016$1,834.1    $853.3    $1,068.9   

__________  (1)  Represents the incremental sales, orders and order backlog as a result of our acquisitions of RootsTM blowers and compressors and Simsmart Technologies.

Contact: Terry Ross, Vice President of Investor Relations Colfax Corporation 301-323-9054 Terry.Ross@colfaxcorp.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sungrow's Keeper Family: Revolutionizing C&I Energy Storage

Updated Category News Views 86

The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 70

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 78

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Gaotu Techedu's Q3 Results: A Look at AI-Driven Growth

Updated Category News Views 11

Gaotu Techedu to Unveil Q3 Results Mark your calendars, folks—Gaotu Techedu Inc. (NYSE: GOTU) is gearing up to dish out its third quarter financial results on November 25, 2026. As usual, these numbers will slide out before the U.S. markets spring into action. It's one of those moments when investors like us strap in and watch for any movement that might toss our...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 30

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 165

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 121

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 39

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Matt Hougan Shares Insights on Bitcoin's Potential Surge

Updated Category News Views 165

Understanding Bitcoin's Growth Potential Matt Hougan, the Chief Investment Officer at Bitwise, sheds light on the driving forces behind the burgeoning interest in Bitcoin. He emphasizes concerns over the decline of fiat currencies and noteworthy inflows into Bitcoin ETFs as the catalysts propelling Bitcoin's journey towards new heights. This surge towards potential record...

Continue Reading
Empowering Futures: Access Bank's Commitment to Education

Updated Category News Views 174

Support for Educational Development In recent years, The Access Bank UK Ltd has made significant strides in supporting educational initiatives aimed at transforming lives. This commitment is exemplified by the annual Polo Cup event that they host in collaboration with UNICEF and Fifth Chukker. The Access Bank Cup has become more than just a sporting affair; it is a beacon...

Continue Reading
Gary Brecka's Event Redefines Longevity's Future in L.A.

Updated Category News Views 46

Exploring Longevity: A Day Like No Other Alright, picture this: a convergence of wellness diehards, human performance buffs, and curious minds, all filing into the Peacock Theater in Los Angeles. It's August 16th and they're here for Gary Brecka LIVE. This is no run-of-the-mill wellness seminar; it's an exclusive deep dive into the world of longevity hosted by Sequel...

Continue Reading
Ultragenyx Pharmaceutical and Others Face Challenges in Ratings

Updated Category News Views 164

Stock Market Overview This morning, U.S. stock futures indicated a downward trend, with the Dow futures decreasing by about 100 points. Given the numerous fluctuations in the market recently, this drop is indicative of the challenges many companies are facing. Ultragenyx Pharmaceutical Inc Performance Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have sharply...

Continue Reading
Netflix's Future: Overcoming Slower Subscriber Growth Strategies

Updated Category News Views 185

Analyzing Netflix's Subscription Growth and Future Strategies Netflix, a leading name in streaming services, is facing a potential slowdown in subscriber additions. Analysts suggest that the streaming giant might experience its most modest subscriber growth in the past six quarters as the gains from its recent password-sharing crackdown start to wane. With this shifting...

Continue Reading